VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 25 filers reported holding VASCULAR BIOGENICS LTD in Q1 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $45,000 | -10.0% | 37,500 | 0.0% | 0.00% | – |
| Q3 2019 | $50,000 | +2.0% | 37,500 | 0.0% | 0.00% | – |
| Q2 2019 | $49,000 | +44.1% | 37,500 | +66.7% | 0.00% | – |
| Q1 2019 | $34,000 | +54.5% | 22,500 | 0.0% | 0.00% | – |
| Q4 2018 | $22,000 | -40.5% | 22,500 | 0.0% | 0.00% | – |
| Q3 2018 | $37,000 | -41.3% | 22,500 | -17.7% | 0.00% | -100.0% |
| Q2 2018 | $63,000 | 0.0% | 27,330 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $63,000 | -66.3% | 27,330 | +3.8% | 0.00% | -50.0% |
| Q4 2017 | $187,000 | +34.5% | 26,330 | +15.3% | 0.00% | 0.0% |
| Q3 2017 | $139,000 | +36.3% | 22,830 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $102,000 | +41.7% | 22,830 | +75.6% | 0.00% | 0.0% |
| Q1 2017 | $72,000 | +200.0% | 13,000 | +160.0% | 0.00% | – |
| Q4 2016 | $24,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
| Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
| DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
| PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
| Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
| Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
| HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
| MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
| Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |